Fulcrum Therapeutics, Inc. (FULC) quarterly cash flow statement — complete operating, investing & financing history
Fulcrum Therapeutics, Inc. (FULC) cash flow statement — 9-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -16.04M | -18.75M | -16.8M | -14.19M | -13.82M | -15.26M | -16.76M | -19.07M | 58.9M | -25.28M | -23.16M | -22.91M | -20.79M | -24.12M | -19.7M | -27.88M | -27.37M | -22.11M | -21.86M | -22.57M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | 73.62% | - | -2658.78% | -3017.92% | -2361.93% | -8174.92% | -2875.33% | -2356.89% | -1454.09% | -852.85% | -432.15% | -457.41% |
| Operating CF Growth % | -16.06% | -22.89% | -0.22% | 25.6% | -123.46% | 39.66% | 27.62% | 16.74% | 383.37% | -4.84% | -17.58% | 17.85% | 24.05% | -9.09% | 9.89% | -23.52% | -53.56% | -36.24% | -10.25% | -401.18% |
| Net Income | -26.18M | -18.89M | -20.33M | -19.59M | -17.3M | -17.66M | -16.57M | -21.7M | 55.41M | -26.87M | -24.76M | -24.02M | -23.78M | -24.78M | -26.14M | -23.74M | -34.07M | -25.93M | -23.48M | -20.72M |
| Depreciation & Amortization | 216K | 338K | 347K | 346K | 344K | 353K | 369K | 400K | 400K | 479K | 508K | 531K | 567K | 566K | 591K | 611K | 676K | 536K | 621K | 619K |
| Stock-Based Compensation | 3.27M | 3.86M | 3.07M | 3.36M | 2.88M | 3.17M | 2.48M | 3.82M | 4.34M | 3.92M | 3.45M | 3.74M | 3.36M | 4.25M | 3.27M | 3.35M | 2.88M | 3.85M | 3.79M | 2.66M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 4.28M | -767K | -383K | -586K | -1.08M | -899K | -945K | 2.63M | 3.19M | -1.16M | -1.33M | -1.58M | -1.71M | -1.37M | -601K | 112K | 288K | 353K | 386K | 92K |
| Working Capital Changes | 2.38M | -3.29M | 506K | 2.29M | 1.34M | -223K | -2.09M | -410K | -96K | -1.65M | -1.03M | -1.57M | 780K | -2.79M | 3.18M | -8.22M | 2.86M | -914K | -3.17M | -5.23M |
| Change in Receivables | 0 | 0 | 0 | 0 | 979K | 1.12M | 1.56M | -1.32M | -2.33M | 537K | 43K | 76K | -557K | 130K | 574K | 344K | -298K | 2.83M | -2.47M | -511K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 975K | 858K | -1.1M | 946K | 244K | 343K | -2.7M | 297K | -293K | 1.1M | -817K | -287K | 163K | 88K | 903K | -2.55M | -38K | 509K | 1.18M | -825K |
| Cash from Investing | 13.78M | -128.21M | -1.05M | 18.61M | 13.93M | -777K | 2.26M | 4.35M | -12.51M | 38.13M | 18.35M | 19.02M | 19.88M | -93.94M | -36.36M | -2.28M | 31.39M | 19.66M | -9.09M | -106.64M |
| Capital Expenditures | -108K | -8K | -159K | -90K | -65K | 0 | -231K | -19K | 0 | -28K | -77K | -65K | -195K | -171K | -116K | -283K | -1.32M | -246K | -519K | -367K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | 8.84% | 8.56% | 22.16% | 57.97% | 16.93% | 23.92% | 70.03% | 9.49% | 10.26% | 7.44% |
| Acquisitions | 450K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 93.77M | 0 | 2M | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -93.77M | 0 | -2M | 0 | 0 | 0 | 0 |
| Cash from Financing | 356K | -312K | 168.3M | 64K | 301K | 0 | 83K | 635K | 377K | 1.65M | 287K | 0 | 142K | 117.69M | 218K | 80.95M | 2.81M | 348K | 891K | 137.9M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1K | 1K |
| Equity Issued (Net) | 356K | 21K | 168.3M | 64K | 301K | 0 | 83K | 635K | 377K | 1.65M | 287K | 0 | 0 | 117.34M | -49K | 80.85M | 0 | 0 | -77K | 135.53M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -333K | 0 | 0 | 0 | 0 | 83K | 0 | 0 | 0 | 0 | 0 | 142K | 348K | 267K | 93K | 2.81M | 348K | 969K | 2.38M |
| Net Change in Cash | -1.9M | -147.27M | 150.46M | 4.49M | 414K | -16.03M | -14.42M | -14.07M | 46.75M | 14.39M | -4.52M | -3.89M | -768K | -364K | -55.84M | 50.78M | 6.84M | -2.1M | -30.06M | 8.69M |
| Free Cash Flow | -16.15M | -18.76M | -16.96M | -14.28M | -13.88M | -15.26M | -16.99M | -19.09M | 58.9M | -25.31M | -23.23M | -22.97M | -20.98M | -24.29M | -19.81M | -28.16M | -28.68M | -22.35M | -22.38M | -22.94M |
| FCF Margin % | - | - | - | - | - | - | - | - | 73.62% | - | -2667.62% | -3026.48% | -2384.09% | -8232.88% | -2892.26% | -2380.81% | -1524.12% | -862.35% | -442.41% | -464.84% |
| FCF Growth % | -16.29% | -22.95% | 0.21% | 25.2% | -123.57% | 39.72% | 26.87% | 16.89% | 380.74% | -4.22% | -17.28% | 18.44% | 26.86% | -8.66% | 11.46% | -22.78% | -56.01% | -35.57% | -10.24% | -399.02% |
| FCF per Share | -0.21 | -0.25 | -0.27 | -0.23 | -0.22 | -0.24 | -0.31 | -0.31 | 0.93 | -0.41 | -0.38 | -0.37 | -0.34 | -0.41 | -0.38 | -0.61 | -0.70 | -0.55 | -0.55 | -0.63 |
| FCF Conversion (FCF/Net Income) | 0.61x | 0.99x | 0.83x | 0.72x | 0.80x | 0.86x | 1.01x | 0.88x | 1.06x | 0.94x | 0.94x | 0.95x | 0.87x | 0.97x | 0.75x | 1.17x | 0.80x | 0.85x | 0.93x | 1.09x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 652K | 0 | 0 | 0 | 0 | 0 | 0 | 827K | 0 | 0 | 0 | 803K | 597K | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |